Athero Slider
[metaslider id="4918"]

AtheroEdge™ Overview

AtheroEdge is 510 (K) cleared and is the first software on the market that offers fully-automated carotid IMT measurement by ultrasound. It is a fully automated c-IMT technology that completes in 5 seconds what semi-automatic systems do in several minutes.

Used By

ap logolg web1 300x64

Neurologists

ap logolg web1 300x64

Radiologists

ap logolg web1 300x64

Vascular Surgeons

ap logolg web1 300x64

Cardiologists

ap logolg web1 300x64

Internists

ap logolg web1 300x64

Endocrinologists

ap logolg web1 300x64

Pediatricians

Applications

ap logolg web1 300x64

Stroke

ap logolg web1 300x64

Peripheral Vascular Disease

ap logolg web1 300x64

Brain Degeneration

ap logolg web1 300x64

Cardiovascular Disease

ap logolg web1 300x64

Diabetes

TRUSTED BY HEALTHCARE PROFESSIONALS

WE PROVIDE ACCURATE MEDICAL ANALYSIS

Patient Reports Analyzed
0 +
Healthcare Professionals
0 +
Years Of Innovation
0 +
Report Accuracy Rate
0 %

Services

Intelligent Vascular Analysis Services

AtheroPoint provides services in form of processing the patient data through its propriety AtheroEdge™ software, to perform early diagnosis through speedy and accurate reporting. AtheroEdge™ estimates Lumen-Intima (LI) and Media-Adventitia (MA) borders and automatically measures the Intima-Media Thickness (IMT) of the longitudinal carotid artery images provided by the user.

  • AtheroEdge Preview
  • Evidence
  • Service
  • Diabetes & Atheroslerosis

Ikeda N, Saba L, Molinari F, Piga M, Meiburger K, Sugi K, Porcu M, Bocchiddi L, Acharya UR, Nakamura M, Nakano M, Nicolaides A, Suri JS.

Molinari F, Meiburger KM, Zeng G, Saba L, Rajendra Acharya U, Famiglietti L, Georgiou N, Nicolaides A, Sriswan Mamidi R, Kuper H, Suri JS.

Saba L, Meiburger KM, Molinari F, Ledda G, Anzidei M, Acharya UR, Zeng G, Shafique S, Nicolaides A, Suri JS.

AtheroPoint provides services in form of processing the patient data through its propriety AtheroEdge™ software, to perform early diagnosis through speedy and accurate reporting. AtheroEdge™ estimates Lumen-Intima (LI) and Media-Adventitia (MA) borders and automatically measures the Intima-Media Thickness (IMT) of the longitudinal carotid artery images provided by the user.

Free Evaluation/Free Trial

The Company offers a free evaluation program for evaluating the product prior to purchasing. The Company will process up to 25 image frames of patients and provide the reports to the physician for assessment during the trial period.

Enrollment Options

After the evaluation period, physicians can enroll with the Company for 6 months, 12 months or longer term to process their patient image database. The service cost will vary depending upon the number of patients included in the database of the enrolling physician or office. All inquiries for quotes should be directed to sales@atheropoint.com.

AtheroPoint™ partners with Torino University, Italy.

AtheroPoint™ receives IRB with Elizabeth Hospital, IN, USA.

AtheroPoint™ partners with Wake Forest University, NC, USA.

AtheroPoint™ benchmarks AtheroEdge™ against Siemens's Syngo.

AtheroPoint™ benchmarks AtheroEdge™ against Carotid CT.

AtheroPoint™'s AtheroEdge™ Receives 510(K) FDA Clearance.

AtheroPoint™'s Cloud Storage is HIPPA Compliant.

AtheroPoint™ completes web-based ImgTracer™ for any imaging modality.

AtheroPoint™ gets place in international journals.

AtheroPoint™ gets a place in Current Atherosclerosis Reports (CAR) journal on Peripheral Vascular Disease (PVD) and carotid IMT variability.

AtheroPoint™ gets place in Journal of Magnetic Resonance Imaging (JMRI).

AtheroPoint™ gets a place in International Angiology Journal for estimating Calcium volume from IVUS.

At AtheroPoint we aim to revolutionize the screening, diagnosis, monitoring and management of cardiovascular disease (CVD). Call us today about AtheroEdge at 916-749-5628.

AtheroPoint™

Monitoring Made Simple

  • AtheroEdge Preview
  • Evidence
  • Service
  • Diabetes & Atheroslerosis

Ikeda N, Saba L, Molinari F, Piga M, Meiburger K, Sugi K, Porcu M, Bocchiddi L, Acharya UR, Nakamura M, Nakano M, Nicolaides A, Suri JS.

Molinari F, Meiburger KM, Zeng G, Saba L, Rajendra Acharya U, Famiglietti L, Georgiou N, Nicolaides A, Sriswan Mamidi R, Kuper H, Suri JS.

Saba L, Meiburger KM, Molinari F, Ledda G, Anzidei M, Acharya UR, Zeng G, Shafique S, Nicolaides A, Suri JS.

AtheroPoint provides services in form of processing the patient data through its propriety AtheroEdge™ software, to perform early diagnosis through speedy and accurate reporting. AtheroEdge™ estimates Lumen-Intima (LI) and Media-Adventitia (MA) borders and automatically measures the Intima-Media Thickness (IMT) of the longitudinal carotid artery images provided by the user.

Free Evaluation/Free Trial

The Company offers a free evaluation program for evaluating the product prior to purchasing. The Company will process up to 25 image frames of patients and provide the reports to the physician for assessment during the trial period.

Enrollment Options

After the evaluation period, physicians can enroll with the Company for 6 months, 12 months or longer term to process their patient image database. The service cost will vary depending upon the number of patients included in the database of the enrolling physician or office. All inquiries for quotes should be directed to sales@atheropoint.com.

AtheroPoint™ partners with Torino University, Italy.

AtheroPoint™ receives IRB with Elizabeth Hospital, IN, USA.

AtheroPoint™ partners with Wake Forest University, NC, USA.

AtheroPoint™ benchmarks AtheroEdge™ against Siemens's Syngo.

AtheroPoint™ benchmarks AtheroEdge™ against Carotid CT.

AtheroPoint™'s AtheroEdge™ Receives 510(K) FDA Clearance.

AtheroPoint™'s Cloud Storage is HIPPA Compliant.

AtheroPoint™ completes web-based ImgTracer™ for any imaging modality.

AtheroPoint™ gets place in international journals.

AtheroPoint™ gets a place in Current Atherosclerosis Reports (CAR) journal on Peripheral Vascular Disease (PVD) and carotid IMT variability.

AtheroPoint™ gets place in Journal of Magnetic Resonance Imaging (JMRI).

AtheroPoint™ gets a place in International Angiology Journal for estimating Calcium volume from IVUS.

At AtheroPoint we aim to revolutionize the screening, diagnosis, monitoring and management of cardiovascular disease (CVD). Call us today about AtheroEdge at 916-749-5628.

AtheroPoint™

Monitoring Made Simple

Why AtheroEdge

Typically in clinical practice, IMT is measured along the far (posterior) wall of the common carotid artery bilaterally proximal to the bifurcation and within 1 cm and 2 cm from the bifurcation to the carotid bulb. AtheroEdge™ performs automated IMT measurements in the far wall of the common carotid artery. AtheroEdge™ software automatically identifies multiple number of points along the carotid artery in the ultrasound images and computes IMT at these points. These multiple measurements are usable in tracking the progression or regression of atherosclerotic plaques in the carotid artery over time.

WE ARE HERE FOR YOU

MAKE AN APPOINTMENT TODAY

PLEASE FILL A FORM

News & Update